Lobbying

H Lee Moffitt Cancer Center & Research Institute's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $10K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.

H Lee Moffitt Cancer Center & Research Institute

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$10K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

H Lee Moffitt Cancer Center & Research Institute lobbying by quarter
H Lee Moffitt Cancer Center & Research Institute lobbying by quarter
QuarterAmountReports
Q4 2022$130K1
Q1 2023$120K1
Q2 2023$120K1
Q3 2023$120K1
Q4 2023$110K1
Q1 2024$110K1
Q2 2024$120K1
Q3 2024$10K1
Q4 2024$20K1
Q1 2025$10K1
Q2 2025$01
Q3 2025$01
Q4 2025$10K1
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Health issues$552.5K · 15 reports
  • Budget and appropriations$322.5K · 13 reports
  • Economic development$2,500 · 3 reports
  • Pharmacy$2,500 · 3 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Centers For Medicare and Medicaid Services (CMS)8 reports
  • Defense, Dept of (DOD)8 reports
  • Health & Human Services, Dept of (HHS)7 reports
  • White House Office7 reports

Firms it paid

Firm
In-houseH. Lee Moffitt Cancer Center & Research Institute$880K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/27for Q2In-houseUnder $5,000
05/05for Q1In-houseUnder $5,000
02/16for Q4 2025In-house$10K
25/10/20for Q3 2025In-houseUnder $5,000
25/07/18for Q2 2025In-houseUnder $5,000
25/06/25for Q1 2025In-house$10K
25/04/20for Q1 2025In-house$10K
25/04/20for Q4 2024In-house$20K
24/11/13for Q3 2024In-house$10K
24/08/07for Q2 2024In-house$120K
24/07/02for Q2 2024In-house$120K
24/04/02for Q1 2024In-house$110K
24/01/08for Q4 2023In-house$110K
23/10/05for Q3 2023In-house$120K
23/07/10for Q2 2023In-house$120K
23/04/06for Q1 2023In-house$120K
23/01/09for Q4 2022In-house$130K